Lenograstim [clinicaltrials_resource:d61771c8bce12df397de64f584884b31]
Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease [clinicaltrials:NCT00000626]A Study of Stem Cells and Filgrastim [clinicaltrials:NCT00001071]A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients [clinicaltrials:NCT00001272]A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients [clinicaltrials:NCT00001384]clinicaltrials:NCT00001529Study of Mast Cell Precursors [clinicaltrials:NCT00001756]G-CSF for Granulocyte Donation [clinicaltrials:NCT00001842]A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection. [clinicaltrials:NCT00002126]An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC) [clinicaltrials:NCT00002255]A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex [clinicaltrials:NCT00002281]Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002501]Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma [clinicaltrials:NCT00002539]clinicaltrials:NCT00002571clinicaltrials:NCT00002610clinicaltrials:NCT00002740clinicaltrials:NCT00002804clinicaltrials:NCT00002827clinicaltrials:NCT00002833clinicaltrials:NCT00002836Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer [clinicaltrials:NCT00002913]clinicaltrials:NCT00003093clinicaltrials:NCT00003138clinicaltrials:NCT00003141clinicaltrials:NCT00003178clinicaltrials:NCT00003217clinicaltrials:NCT00003573Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003597]clinicaltrials:NCT00003739clinicaltrials:NCT00003926Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma [clinicaltrials:NCT00003929]clinicaltrials:NCT00004055clinicaltrials:NCT00004056clinicaltrials:NCT00004188Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer [clinicaltrials:NCT00004189]Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma [clinicaltrials:NCT00004192]Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes [clinicaltrials:NCT00004787]clinicaltrials:NCT00004853clinicaltrials:NCT00005578Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait [clinicaltrials:NCT00005782]clinicaltrials:NCT00005810
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Lenograstim [clinicaltrials_resource:d61771c8bce12df397de64f584884b31]
Bio2RDF identifier
d61771c8bce12df397de64f584884b31
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d61771c8bce12df397de64f584884b31
identifier
clinicaltrials_resource:d61771c8bce12df397de64f584884b31
title
Lenograstim
@en
type
label
Lenograstim [clinicaltrials_resource:d61771c8bce12df397de64f584884b31]
@en